Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer.
about
Long Non-coding RNAs and Their Roles in Non-small-cell Lung CancerPCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancerAn overview of long non-coding RNAs in ovarian cancersPSA and beyond: alternative prostate cancer biomarkersPotential Utility of Novel Biomarkers in Active Surveillance of Low-Risk Prostate CancerComprehensive assessment for novel prostate cancer markers in the prostate-specific antigen era: focusing on Asians and Asian countriesUrinary biomarkers for prostate cancerBiomarkers in prostate cancer: what's new?Prostate cancer biomarkers: Are we hitting the mark?Long Non-coding RNAs in Urologic Malignancies: Functional Roles and Clinical TranslationProstate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal BiomarkersEvolving transcriptomic fingerprint based on genome-wide data as prognostic tools in prostate cancerDiscovering and understanding oncogenic gene fusions through data intensive computational approachesProstate cancer proteomics: Current trends and future perspectives for biomarker discovery.Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancerAndrogen regulation of the TMPRSS2 gene and the effect of a SNP in an androgen response elementThe Xu's chart for prostate biopsy: a visual presentation of the added value of biomarkers to prostate-specific antigen for estimating detection rates of prostate cancer.Molecular pathways and targets in prostate cancerPrevention and early detection of prostate cancer.Potential utility of cancer-specific biomarkers for assessing response to hormonal treatments in metastatic prostate cancer.The biology of castration-resistant prostate cancerAnalytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods.Integrated analysis of DNA methylation and microRNA regulation of the lung adenocarcinoma transcriptome.Comparison of Multiparametric MRI Scoring Systems and the Impact on Cancer Detection in Patients Undergoing MR US Fusion Guided Prostate Biopsies.Using gene expression from urine sediment to diagnose prostate cancer: development of a new multiplex mRNA urine test and validation of current biomarkers.Toward Precision Medicine: A Cancer Molecular Subtyping Nano-Strategy for RNA Biomarkers in Tumor and Urine.RNA biomarkers to facilitate the identification of aggressive prostate cancerProstasomes as a source of diagnostic biomarkers for prostate cancer.Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer.The use of a gas chromatography-sensor system combined with advanced statistical methods, towards the diagnosis of urological malignancies.Sensitive detection and glycoprofiling of a prostate specific antigen using impedimetric assays.Long noncoding RNAs in prostate cancer: mechanisms and applicationsThe present and future of prostate cancer urine biomarkers.Personalized prostate cancer care: from screening to treatment.A simple, rapid, low-cost technique for naked-eye detection of urine-isolated TMPRSS2:ERG gene fusion RNA.Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa)Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer.Prostate-based biofluids for the detection of prostate cancer: A comparative study of the diagnostic performance of cell-sourced RNA biomarkers.Biomarkers in prostate cancer surveillance and screening: past, present, and future.Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag.
P2860
Q26743412-E2DEF952-9849-4EF4-A40D-3FFDABD4053EQ26752933-0280CB5E-38A9-4CBB-AE6B-EDBC9D818CE4Q26753467-B38797FB-C6EA-44FD-AA30-A0FC08D620D1Q26770646-C3F8A711-0B96-4400-ACF8-C862FC860813Q26784517-B8832AF7-3484-4B02-A618-AE3DFF8517E2Q26996461-1E860C6C-588A-4BDD-B362-4BFF8E0869DBQ27009110-59DBE94E-C8FC-4AAC-BFEA-250E15A4EF68Q27026210-0E17F312-5609-4209-8814-DA0BB021427AQ28071654-15EFA01C-D36B-4B25-B202-B3379DBFAA48Q28071872-6A2E668F-D57A-45F2-8322-76FB6B19790FQ28075610-43CD05B7-8257-4C8E-996F-0469FCC25F50Q30938412-800664C5-62B7-4C91-B681-F25881162E8FQ31083417-C79884F0-92C5-48E9-8E21-7A25C188D28AQ33567004-A2E93E3F-BFDD-4ABF-8730-B4DAD7D53DB4Q33644807-4D3C672A-4A83-47F2-BE00-4BDCF11B65BEQ33663401-D208C6BD-50BF-49CF-A029-822E7B85217BQ33922385-5633F8D6-49D8-424C-BC28-57F71E23482CQ34365632-91350149-2852-4980-A53D-BE8F8DF8FCCAQ34371057-8551F2E3-8F40-48FC-9102-D25A626C8F32Q34536729-5585B524-CA9D-4A5B-B312-C58A5C8858D7Q35039889-4DD8E570-E680-4C22-BBB6-05AD0346660AQ35125405-D8273B0D-9364-434D-AA14-9ABEC2D90B56Q35805617-1D55A3E7-CBAC-4025-86C7-08D1750639DCQ35852107-4A189E83-F6CE-404A-8935-D0F637A10590Q35917562-79579C7D-E8D2-418B-A3A5-8D98653E61ECQ36157852-8C6E267D-2C14-4A17-AF8A-AB6C2D4FA833Q36260364-0D940CF9-4B68-4B95-8420-0DEDAC1A70D5Q36737927-24E5C45E-A38C-4B6B-B9E3-214AAD123D34Q36848024-AF6CBCB3-10C6-4632-BCF6-DD3E6B570CE6Q36926798-8A9F2BBC-05A3-4CD5-ACAF-11CE689948A4Q36945404-83CD44BD-42BF-4842-BD67-6DC8BF407925Q36997564-9EB5599E-B216-4152-B545-05790CDEA960Q37007392-1A6DA36B-DFB3-4FFB-8361-590CBEB7DA9AQ37113160-A4515041-860C-4EE0-8D57-CE46B557FDDEQ37137366-6E2A2ADA-DC1A-4153-B94B-2B284B0E601BQ37155070-1D20008F-2792-462F-A025-F02AE6543AFDQ37246050-239F1379-6BC6-4718-9E1A-B85632A58477Q37273884-86C20E99-FCE7-41FD-B8E0-A4F3E02DAFE1Q37300931-CB346AEC-3069-4161-9BAC-DC0FC4CE74E8Q37635618-911902DF-B49A-475D-87A3-0F29FFB7EFB4
P2860
Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Prospective multicentre evalua ...... iomarkers for prostate cancer.
@en
type
label
Prospective multicentre evalua ...... iomarkers for prostate cancer.
@en
prefLabel
Prospective multicentre evalua ...... iomarkers for prostate cancer.
@en
P2093
P1433
P1476
Prospective multicentre evalua ...... iomarkers for prostate cancer.
@en
P2093
Ben C Knipscheer
Christina A Hulsbergen-van de Kaa
Daphne Hessels
Erik B Cornel
Frank P Smit
Gisele H J M Leyten
Hans de Jong
Henk Vergunst
Inge M van Oort
Jack A Schalken
P304
P356
10.1016/J.EURURO.2012.11.014
P407
P577
2012-11-15T00:00:00Z